These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 6205144)

  • 1. Reversal by angiotensins II and III of the effects of converting enzyme inhibition on renal electrolyte excretion in rats.
    Harris PJ; Munro JO
    J Physiol; 1984 Jun; 351():491-500. PubMed ID: 6205144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escape from the sodium-retaining action of intrarenal angiotensins II and III in the conscious dog.
    Dickstein GM; Woodson JF; Lamb NE; Rose CE; Peach MJ; Carey RM
    Endocrinology; 1985 Nov; 117(5):2160-9. PubMed ID: 4042980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin inhibition and renal denervation in two-kidney, one clip hypertensive rats.
    Rademacher R; Berecek KH; Ploth DW
    Hypertension; 1986 Dec; 8(12):1127-34. PubMed ID: 3025089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction between atrial natriuretic peptides and angiotensin II in controlling sodium and water excretion in the rat.
    Chamienia AL; Johns EJ
    Br J Pharmacol; 1991 Aug; 103(4):1893-8. PubMed ID: 1833019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of verapamil and converting enzyme inhibition on bilateral renal function of two-kidney, one-clip hypertensive rats.
    Ploth DW; Kleeman K; Morrill L; Rademacher R; Jackson CA
    Clin Sci (Lond); 1987 Jun; 72(6):657-67. PubMed ID: 3036414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs.
    Kimbrough HM; Vaughan ED; Carey RM; Ayers CR
    Circ Res; 1977 Feb; 40(2):174-8. PubMed ID: 191213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive and renal effects of cilazapril and their reversal by angiotensin in renovascular hypertensive rats.
    Ding YA; Chang ST; Shieh SM; Huang WC
    Clin Sci (Lond); 1988 Apr; 74(4):365-72. PubMed ID: 2965632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal responses to atrial natriuretic factor during converting enzyme inhibition.
    Wang SL; Gilmore JP
    Can J Physiol Pharmacol; 1985 Mar; 63(3):220-3. PubMed ID: 2985222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.
    Morton JJ; Casals-Stenzel J; Lever AF; Millar JA; Riegger AJ; Tree M
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):233S-241S. PubMed ID: 223615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of different angiotensins during acute, double blockade of the renin system in conscious dogs.
    Wamberg C; Plovsing RR; Sandgaard NC; Bie P
    Am J Physiol Regul Integr Comp Physiol; 2003 Nov; 285(5):R971-80. PubMed ID: 12869367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined intrarenal renin-angiotensin blockade alters renal function and this is reversed by angiotensin II.
    Siragy HM; Howell NL; Peach MJ; Carey RM
    J Hypertens Suppl; 1989 Dec; 7(6):S174-5. PubMed ID: 2698923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal Mas and AT
    O'Neill J; Healy V; Johns EJ
    Exp Physiol; 2017 Dec; 102(12):1700-1715. PubMed ID: 28940861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats.
    Jaeger P; Ferguson RK; Brunner HR; Kirchertz EJ; Gavras H
    Kidney Int; 1978 Apr; 13(4):289-96. PubMed ID: 651128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubuloglomerular feedback and single nephron function after converting enzyme inhibition in the rat.
    Ploth DW; Rudulph J; LaGrange R; Navar LG
    J Clin Invest; 1979 Nov; 64(5):1325-35. PubMed ID: 227932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of converting enzyme inhibition on the renal haemodynamic responses to noradrenaline infusion in the rat.
    Arundell LA; Johns EJ
    Br J Pharmacol; 1982 Mar; 75(3):553-8. PubMed ID: 6175369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrarenal aminopeptidase N inhibition augments natriuretic responses to angiotensin III in angiotensin type 1 receptor-blocked rats.
    Padia SH; Kemp BA; Howell NL; Siragy HM; Fournie-Zaluski MC; Roques BP; Carey RM
    Hypertension; 2007 Mar; 49(3):625-30. PubMed ID: 17190872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of brain angiotensin II in the somatosensory induced antinatriuresis in the anaesthetized rat.
    Huang C; Johns EJ
    Clin Exp Pharmacol Physiol; 2000 Mar; 27(3):191-6. PubMed ID: 10744346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of a primary antidiuretic action of angiotensin II: effects of intrarenal converting enzyme inhibition in the conscious dog.
    Levens NR; Peach MJ; Vaughan ED; Carey RM
    Endocrinology; 1981 Jan; 108(1):318-30. PubMed ID: 6161801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensins II and III prevent captopril-induced renin release in the rat.
    Moldenhauer GK; Smith MD; Di Nicolantonio R; Doyle AE; Morgan TO
    Clin Exp Pharmacol Physiol; 1988 Feb; 15(2):113-21. PubMed ID: 3078272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensins II and III on glomerulotubular balance in rats.
    Harris PJ; Zhuo JL; Skinner SL
    Clin Exp Pharmacol Physiol; 1987 Jun; 14(6):489-502. PubMed ID: 3315334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.